Abstract
Heterocyclic N-oxides have emerged as promising agents against a number of diseases and disorders, especially infectious diseases. This review analyzes the emergence and development of this scaffold in the medicinal chemistry, focusing mainly on the discovery of new heterocyclic N-oxide compounds with potent activity against tuberculosis, malaria and neglected tropical diseases (i.e. leishmaniasis and Chagas disease). A number of heterocyclic N-oxides are described herein, nevertheless, the following chemical classes deserve to be highlighted due to a large number of reports in the literature about their promising pharmacological effects: furoxan, benzofuroxan, quinoxaline 1,4-di-N-oxide, indolone N-oxide and benzimidazole N-oxide. In order to describe those most promising compounds, we included in this review only those most biologically active heterocyclic Noxide published since 2000.
Keywords: Heterocyclic N-oxides, N-oxide compounds, tuberculosis, malaria, neglected tropical diseases, leishmaniasis, Chagas disease, drug discovery.
Current Pharmaceutical Design
Title:Heterocyclic N-oxides - A Promising Class of Agents against Tuberculosis, Malaria and Neglected Tropical Diseases
Volume: 24 Issue: 12
Author(s): Guilherme Felipe dos Santos Fernandes, Aline Renata Pavan and Jean Leandro dos Santos*
Affiliation:
- Sao Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara,Brazil
Keywords: Heterocyclic N-oxides, N-oxide compounds, tuberculosis, malaria, neglected tropical diseases, leishmaniasis, Chagas disease, drug discovery.
Abstract: Heterocyclic N-oxides have emerged as promising agents against a number of diseases and disorders, especially infectious diseases. This review analyzes the emergence and development of this scaffold in the medicinal chemistry, focusing mainly on the discovery of new heterocyclic N-oxide compounds with potent activity against tuberculosis, malaria and neglected tropical diseases (i.e. leishmaniasis and Chagas disease). A number of heterocyclic N-oxides are described herein, nevertheless, the following chemical classes deserve to be highlighted due to a large number of reports in the literature about their promising pharmacological effects: furoxan, benzofuroxan, quinoxaline 1,4-di-N-oxide, indolone N-oxide and benzimidazole N-oxide. In order to describe those most promising compounds, we included in this review only those most biologically active heterocyclic Noxide published since 2000.
Export Options
About this article
Cite this article as:
dos Santos Fernandes Felipe Guilherme, Pavan Renata Aline and dos Santos Leandro Jean *, Heterocyclic N-oxides - A Promising Class of Agents against Tuberculosis, Malaria and Neglected Tropical Diseases, Current Pharmaceutical Design 2018; 24 (12) . https://dx.doi.org/10.2174/1381612824666180417122625
DOI https://dx.doi.org/10.2174/1381612824666180417122625 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MIANN Models in Medicinal, Physical and Organic Chemistry
Current Topics in Medicinal Chemistry Rapid Analysis of Pharmacology for Infectious Diseases
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Current Status and Perspective on Drug Targets in Tubercle Bacilli and Drug Design of Antituberculous Agents Based on Structure-Activity Relationship)
Current Pharmaceutical Design The Release and Induced Immune Responses of a Plant-Made and Delivered Antigen in the Mouse Gut
Current Drug Delivery Benzothiazol Clubbed Imidazol-4-ones as Anti-fungal, Anti-tubercular and Anti-HIV-1 Agents: Their Synthesis and Molecular Docking Study
Letters in Drug Design & Discovery Anti-Microbial
Current Bioactive Compounds Diagnostic Accuracy of Monocyte Chemotactic Protein (MCP)-2 as Biomarker in Response to PE35/PPE68 Proteins: A Promising Diagnostic Method for the Discrimination of Active and Latent Tuberculosis
Protein & Peptide Letters Assessment of Glycoproteins Dynamics from Computer Simulations
Mini-Reviews in Organic Chemistry Colloidal Drug Delivery Systems in Vaccine Delivery
Current Drug Targets Molecular Biological Roles of Ursolic Acid in the Treatment of Human Diseases
Current Bioactive Compounds Current Developments in the Synthesis and Biological Activity of HIV-1 Double-Drug Inhibitors
Current Medicinal Chemistry Quasi-Life Self-Organizing Systems: Based on Ensembles of Succinylated Derivatives of Interferon-Gamma
Current Medicinal Chemistry Potential Inhibitor of Adenylyl Sulfate Reductase Isolated from Desulfovibrio desulfuricans with PU/PU-Ag to Control Pitting Corrosion of Oil Tanks and Pipelines
Current Enzyme Inhibition Functional Polymeric Nano/Microparticles for Surface Adsorption and Delivery of Protein and DNA Vaccines
Current Drug Delivery A Method to Prepare Solid Lipid Nanoparticles with Improved Entrapment Efficiency of Hydrophilic Drugs
Current Nanoscience Functions of S100 Proteins
Current Molecular Medicine Graphical Abstracts
Letters in Drug Design & Discovery Editorial (Hot Topic: Vitamin D Deficiency and Critical Illness)
Inflammation & Allergy - Drug Targets (Discontinued) In-Silico Analysis of Imidazo[2,1-b][1,3,4]thiadiazole Analogs as Putative Mycobacterium tuberculosis Enoyl Reductase Inhibitors
Current Drug Therapy Antibodies as Crypts of Antiinfective and Antitumor Peptides
Current Medicinal Chemistry